Sort
4,870 grants matching “glp 1”
The role of amylin and GLP-1 mimetics in the treatment of children with T2DM
$172,627Luisa M Rodriguez · Baylor College Of Medicine · K23 · FY2010 · DK
The role of amylin and GLP-1 mimetics in the treatment of children with T2DM
$172,474Luisa M Rodriguez · Baylor College Of Medicine · K23 · FY2011 · DK
Aging And The Pancreas
$172,341Josephine M Egan · National Institute On Aging · Z01 · FY2008 · AG
Pre-Clinical Vector Production Core
$172,156William F. Goins · Ohio State University · P01 · FY2015 · CA
Core--Formulation Science
$171,593Starpharma, Ltd · U19 · FY2005 · AI
A Novel Microbiome-Based Immune-Modulator that Potentiates Cancer Checkpoint Therapy
$171,480Gary Fanger · Rise Therapeutics, Llc · R44 · FY2024 · CA
Vector Core
$171,190Julie Johnston · University Of Pennsylvania · P01 · FY2011 · HD
Intramuscular lipid and insulin action: ethnic aspects
$170,757Barbara A. Gower · University Of Alabama At Birmingham · R01 · FY2006 · DK
Intramuscular lipid and insulin action: ethnic aspects
$170,670University Of Alabama At Birmingham · R01 · FY2005 · DK
Effect of dipeptidyl peptidase 4 inhibition on growth hormone secretion
$170,584Jessica K Devin · Vanderbilt University Medical Center · K23 · FY2016 · HL
A Yeast-based Immunotherapy against Clostridioides difficile infection
$169,461Zhiyong Yang · Fzata, Inc. · R44 · FY2020 · AI
Oral Small Molecule STAT3 Inhibitor to Treat Cachexia in Chronic Kidney Disease
$169,159David John Tweardy · Stemmed, Ltd · R42 · FY2017 · DK
Impact of obesity and diabetes on coronary microvascular defects in HFpEF
$169,020Deborah Eaton · University Of Pennsylvania · K99 · FY2025 · HL
Microbial activators of host satiety
$168,900Yanjia J Zhang · Boston Children'S Hospital · K08 · FY2025 · DK
Allosteric modulators of the glucagon-like peptide-1 receptor
$168,726Kevin D Niswender · Vanderbilt University · R01 · FY2016 · GM
Pre-Clinical Vector Production Core
$168,622William F. Goins · Ohio State University · P01 · FY2014 · CA
Bacterially-Secreted GLP-1 Induced Reprogramming of Intestinal Cells as a Treatme
$168,530Theodore R Koziol · Biopancreate, Inc. · R41 · FY2012 · DK
Incretin Regulation of Insulin Secretion in Human Neonatal Diabetes
$168,273Siri Atma W. Greeley · University Of Chicago · K23 · FY2014 · DK
Core C - Animal Models Core
$167,938Maria P. Limberis · University Of Pennsylvania · P01 · FY2019 · HL
Core C - Animal Models Core
$167,728Maria P. Limberis · University Of Pennsylvania · P01 · FY2015 · HL
Pharmacologic treatment of thromboembolism
$167,481Tze-Chein Wun · Evas Therapeutics, Llc. · R43 · FY2009 · HL
A live attenuated vaccine for leishmaniasis
$166,973Abhay R. Satoskar · Ohio State University · R21 · FY2019 · AI
Biorepository, Pathology, and Immune Monitoring Core
$166,697Kent J. Weinhold · Duke University · P50 · FY2021 · CA
Modulatory effects of a retinoid-related protein on intestinal endocrine cells
$166,644Rossana M Calderon · Columbia University Health Sciences · K08 · FY2024 · DK
Modulatory effects of a retinoid-related protein on intestinal endocrine cells
$166,644Rossana M Calderon · Columbia University Health Sciences · K08 · FY2025 · DK